Cargando…
Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas
Tertiary lymphoid structures (TLS) are specialized lymphoid formations that serve as local repertoire of T- and B-cells at sites of chronic inflammation, autoimmunity, and cancer. While presence of TLS has been associated with improved response to immune checkpoint blockade therapies and overall out...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647637/ https://www.ncbi.nlm.nih.gov/pubmed/36388913 http://dx.doi.org/10.3389/fmed.2022.981074 |
_version_ | 1784827417773211648 |
---|---|
author | Byers, Candice Gill, Melissa Kurtansky, Nicholas R. Alessi-Fox, Christi Harman, Maggie Cordova, Miguel Gonzalez, Salvador Guitera, Pascale Rotemberg, Veronica Marghoob, Ashfaq Chen, Chih-Shan Jason Dy, Jennifer Kose, Kivanc Rajadhyaksha, Milind Sahu, Aditi |
author_facet | Byers, Candice Gill, Melissa Kurtansky, Nicholas R. Alessi-Fox, Christi Harman, Maggie Cordova, Miguel Gonzalez, Salvador Guitera, Pascale Rotemberg, Veronica Marghoob, Ashfaq Chen, Chih-Shan Jason Dy, Jennifer Kose, Kivanc Rajadhyaksha, Milind Sahu, Aditi |
author_sort | Byers, Candice |
collection | PubMed |
description | Tertiary lymphoid structures (TLS) are specialized lymphoid formations that serve as local repertoire of T- and B-cells at sites of chronic inflammation, autoimmunity, and cancer. While presence of TLS has been associated with improved response to immune checkpoint blockade therapies and overall outcomes in several cancers, its prognostic value in basal cell carcinoma (BCC) has not been investigated. Herein, we determined the prognostic impact of TLS by relating its prevalence and maturation with outcome measures of anti-tumor immunity, namely tumor infiltrating lymphocytes (TILs) and tumor killing. In 30 distinct BCCs, we show the presence of TLS was significantly enriched in tumors harboring a nodular component and more mature primary TLS was associated with TIL counts. Moreover, assessment of the fibrillary matrix surrounding tumors showed discrete morphologies significantly associated with higher TIL counts, critically accounting for heterogeneity in TIL count distribution within TLS maturation stages. Specifically, increased length of fibers and lacunarity of the matrix with concomitant reduction in density and alignment of fibers were present surrounding tumors displaying high TIL counts. Given the interest in inducing TLS formation as a therapeutic intervention as well as its documented prognostic value, elucidating potential impediments to the ability of TLS in driving anti-tumor immunity within the tumor microenvironment warrants further investigation. These results begin to address and highlight the need to integrate stromal features which may present a hindrance to TLS formation and/or effective function as a mediator of immunotherapy response. |
format | Online Article Text |
id | pubmed-9647637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96476372022-11-15 Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas Byers, Candice Gill, Melissa Kurtansky, Nicholas R. Alessi-Fox, Christi Harman, Maggie Cordova, Miguel Gonzalez, Salvador Guitera, Pascale Rotemberg, Veronica Marghoob, Ashfaq Chen, Chih-Shan Jason Dy, Jennifer Kose, Kivanc Rajadhyaksha, Milind Sahu, Aditi Front Med (Lausanne) Medicine Tertiary lymphoid structures (TLS) are specialized lymphoid formations that serve as local repertoire of T- and B-cells at sites of chronic inflammation, autoimmunity, and cancer. While presence of TLS has been associated with improved response to immune checkpoint blockade therapies and overall outcomes in several cancers, its prognostic value in basal cell carcinoma (BCC) has not been investigated. Herein, we determined the prognostic impact of TLS by relating its prevalence and maturation with outcome measures of anti-tumor immunity, namely tumor infiltrating lymphocytes (TILs) and tumor killing. In 30 distinct BCCs, we show the presence of TLS was significantly enriched in tumors harboring a nodular component and more mature primary TLS was associated with TIL counts. Moreover, assessment of the fibrillary matrix surrounding tumors showed discrete morphologies significantly associated with higher TIL counts, critically accounting for heterogeneity in TIL count distribution within TLS maturation stages. Specifically, increased length of fibers and lacunarity of the matrix with concomitant reduction in density and alignment of fibers were present surrounding tumors displaying high TIL counts. Given the interest in inducing TLS formation as a therapeutic intervention as well as its documented prognostic value, elucidating potential impediments to the ability of TLS in driving anti-tumor immunity within the tumor microenvironment warrants further investigation. These results begin to address and highlight the need to integrate stromal features which may present a hindrance to TLS formation and/or effective function as a mediator of immunotherapy response. Frontiers Media S.A. 2022-10-27 /pmc/articles/PMC9647637/ /pubmed/36388913 http://dx.doi.org/10.3389/fmed.2022.981074 Text en Copyright © 2022 Byers, Gill, Kurtansky, Alessi-Fox, Harman, Cordova, Gonzalez, Guitera, Rotemberg, Marghoob, Chen, Dy, Kose, Rajadhyaksha and Sahu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Byers, Candice Gill, Melissa Kurtansky, Nicholas R. Alessi-Fox, Christi Harman, Maggie Cordova, Miguel Gonzalez, Salvador Guitera, Pascale Rotemberg, Veronica Marghoob, Ashfaq Chen, Chih-Shan Jason Dy, Jennifer Kose, Kivanc Rajadhyaksha, Milind Sahu, Aditi Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas |
title | Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas |
title_full | Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas |
title_fullStr | Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas |
title_full_unstemmed | Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas |
title_short | Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas |
title_sort | tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647637/ https://www.ncbi.nlm.nih.gov/pubmed/36388913 http://dx.doi.org/10.3389/fmed.2022.981074 |
work_keys_str_mv | AT byerscandice tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT gillmelissa tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT kurtanskynicholasr tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT alessifoxchristi tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT harmanmaggie tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT cordovamiguel tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT gonzalezsalvador tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT guiterapascale tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT rotembergveronica tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT marghoobashfaq tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT chenchihshanjason tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT dyjennifer tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT kosekivanc tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT rajadhyakshamilind tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas AT sahuaditi tertiarylymphoidstructuresaccompaniedbyfibrillarymatrixmorphologyimpactantitumorimmunityinbasalcellcarcinomas |